Human‐specific vulnerabilities and compensatory adaptations to age‐related stressors in selectively vulnerable midbrain dopaminergic neurons
Project Number1R01AG087959-01
Contact PI/Project LeaderPOLLEN, ALEXANDER A Other PIs
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
PROJECT SUMMARY
The evolutionary expansion of the brain along the primate lineage involved unequal scaling of
brain regions, with telencephalon size increasing dramatically more than that of midbrain and
hindbrain. Coupled with increased human lifespan, this reconfiguration of brain structures may
put undue burden on neurons whose target regions have expanded disproportionately. These
vulnerable “joints” include the small populations of midbrain dopaminergic (DA) neurons that
project to vast target fields in the cortex and striatum and contribute to human-enriched disorders
such as Parkinson’s disease. In turn, human DA neurons may have evolved compensatory
neuroprotective mechanisms while adapting to supplying an enlarged telencephalon, but few
studies have examined the evolution of selective vulnerability or compensatory mechanisms in
the human lineage.
We have designed an interdisciplinary approach to study human-specific properties of DA
neurons using interspecies stem cell-derived organoids, primary tissue from human, chimpanzee,
and rhesus macaque, machine learning approaches to genomics data, and functional analysis of
variants by CRISPR. Our approach will enable direct measurement of dynamic gene regulatory
responses and candidate protective pathways to age-related oxidative stress that cannot be
measured from post-mortem tissue alone. Convolutional neural nets will help decode a dynamic
regulatory grammar of oxidative stress responses, enabling predictions of the effects of all human-
specific variants. Interspecies tetraploid cell fusions further enable experimental analysis of the
effects of these variants in their native genomic context, with CRISPRi supporting further
validation. Finally, comparative loss of function screening in dopaminergic neurons exposed to
stress pathways will reveal conserved and human-specific genetic dependencies in these
vulnerable cell types.
Through the successful completion of these studies, we will determine which genomic
elements and genetic changes underlie oxidative stress-dependent responses in dopaminergic
neurons laying the groundwork for further targeting these cellular protective mechanisms across
cell types and age-related stressors. Ultimately, this approach is generalizable to other age-
related stressors and vulnerable cell types.
Public Health Relevance Statement
PROJECT NARRATIVE
Dopaminergic neurons are particularly sensitive to age-related oxidative stress, and evolutionary changes in the
human lineage exacerbate this vulnerability by extending lifespan and disproportionately expanding axonal target
regions, while requiring increased innervation density in multiple basal ganglia regions. We will use experimental,
computational, and functional methods in human and non-human primate stem cell-derived dopaminergic
neurons, complemented by analysis of primary brain substantia nigra tissue to identify human-specific oxidative
stress-responsive regulatory elements and genes supporting neuroprotective compensatory adaptations. As
many age-related disorders involve damage from oxidative stress, understanding evolved mechanisms of
neuroprotection in a particularly vulnerable neuron will support general strategies aimed at targeting dynamic
oxidative stress responsive elements and pathways in aging.
No Sub Projects information available for 1R01AG087959-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01AG087959-01
Patents
No Patents information available for 1R01AG087959-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01AG087959-01
Clinical Studies
No Clinical Studies information available for 1R01AG087959-01
News and More
Related News Releases
No news release information available for 1R01AG087959-01
History
No Historical information available for 1R01AG087959-01
Similar Projects
No Similar Projects information available for 1R01AG087959-01